Selected research
Industry Growth & Trends
Global Chloroquine Drug for COVID-19 Industry Growth and Trends Forecast to 2032
Market perspective
The global Chloroquine Drug for COVID-19 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Chloroquine Drug for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Chloroquine Drug for COVID-19 include Zhongsheng Pharma, Sichuan Sunny Hope, Shanghai Pharma, Jinghua Pharmaceutical Group, North China Pharmaceutical Group, Guangzhou Baiyunshan Guanghua Pharmaceutical, Bayer, Sun Pharma and Rising Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Chloroquine Drug for COVID-19 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Chloroquine Drug for COVID-19 market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Chloroquine Drug for COVID-19 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Chloroquine Drug for COVID-19.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Chloroquine Drug for COVID-19 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Chloroquine Drug for COVID-19 Market by Company
Zhongsheng Pharma
Sichuan Sunny Hope
Shanghai Pharma
Jinghua Pharmaceutical Group
North China Pharmaceutical Group
Guangzhou Baiyunshan Guanghua Pharmaceutical
Bayer
Sun Pharma
Rising Pharmaceutical
KPC Group
CSPC Group
Chloroquine Drug for COVID-19 Segment by Type
Tablet
Injection
Chloroquine Drug for COVID-19 Segment by Application
Mild Symptom Patient
Critically Ill Patient
Chloroquine Drug for COVID-19 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Drug for COVID-19 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Drug for COVID-19 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Drug for COVID-19.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chloroquine Drug for COVID-19 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Chloroquine Drug for COVID-19 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Injection
Applications
- Mild Symptom Patient
- Critically Ill Patient
Companies covered
- Zhongsheng Pharma
- Sichuan Sunny Hope
- Shanghai Pharma
- Jinghua Pharmaceutical Group
- North China Pharmaceutical Group
- Guangzhou Baiyunshan Guanghua Pharmaceutical
- Bayer
- Sun Pharma
- Rising Pharmaceutical
- KPC Group
- CSPC Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Chloroquine Drug for COVID-19 Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Chloroquine Drug for COVID-19 Sales Estimates and Forecasts (2021-2032)
- 1.3 Chloroquine Drug for COVID-19 Market by Type
- 1.3.1 Tablet
- 1.3.2 Injection
- 1.4 Global Chloroquine Drug for COVID-19 Market Size by Type
- 1.4.1 Global Chloroquine Drug for COVID-19 Market Size Overview by Type (2021-2032)
- 1.4.2 Global Chloroquine Drug for COVID-19 Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Chloroquine Drug for COVID-19 Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Chloroquine Drug for COVID-19 Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Chloroquine Drug for COVID-19 Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Chloroquine Drug for COVID-19 Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Chloroquine Drug for COVID-19 Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Chloroquine Drug for COVID-19 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Chloroquine Drug for COVID-19 Industry Trends
- 2.2 Chloroquine Drug for COVID-19 Industry Drivers
- 2.3 Chloroquine Drug for COVID-19 Industry Opportunities and Challenges
- 2.4 Chloroquine Drug for COVID-19 Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Chloroquine Drug for COVID-19 Revenue (2021-2026)
- 3.2 Global Top Players by Chloroquine Drug for COVID-19 Sales (2021-2026)
- 3.3 Global Top Players by Chloroquine Drug for COVID-19 Price (2021-2026)
- 3.4 Global Chloroquine Drug for COVID-19 Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Chloroquine Drug for COVID-19 Major Company Production Sites & Headquarters
- 3.6 Global Chloroquine Drug for COVID-19 Company, Product Type & Application
- 3.7 Global Chloroquine Drug for COVID-19 Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Chloroquine Drug for COVID-19 Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Chloroquine Drug for COVID-19 Players Market Share by Revenue in 2025
- 3.8.3 2025 Chloroquine Drug for COVID-19 Tier 1, Tier 2, and Tier 3
4 Chloroquine Drug for COVID-19 Regional Status and Outlook
- 4.1 Global Chloroquine Drug for COVID-19 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Chloroquine Drug for COVID-19 Historic Market Size by Region
- 4.2.1 Global Chloroquine Drug for COVID-19 Sales in Volume by Region (2021-2026)
- 4.2.2 Global Chloroquine Drug for COVID-19 Sales in Value by Region (2021-2026)
- 4.2.3 Global Chloroquine Drug for COVID-19 Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Chloroquine Drug for COVID-19 Forecasted Market Size by Region
- 4.3.1 Global Chloroquine Drug for COVID-19 Sales in Volume by Region (2027-2032)
- 4.3.2 Global Chloroquine Drug for COVID-19 Sales in Value by Region (2027-2032)
- 4.3.3 Global Chloroquine Drug for COVID-19 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Chloroquine Drug for COVID-19 by Application
- 5.1 Chloroquine Drug for COVID-19 Market by Application
- 5.1.1 Mild Symptom Patient
- 5.1.2 Critically Ill Patient
- 5.2 Global Chloroquine Drug for COVID-19 Market Size by Application
- 5.2.1 Global Chloroquine Drug for COVID-19 Market Size Overview by Application (2021-2032)
- 5.2.2 Global Chloroquine Drug for COVID-19 Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Chloroquine Drug for COVID-19 Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Chloroquine Drug for COVID-19 Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Chloroquine Drug for COVID-19 Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Chloroquine Drug for COVID-19 Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Chloroquine Drug for COVID-19 Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Chloroquine Drug for COVID-19 Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zhongsheng Pharma
- 6.1.1 Zhongsheng Pharma Company Information
- 6.1.2 Zhongsheng Pharma Business Overview
- 6.1.3 Zhongsheng Pharma Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zhongsheng Pharma Chloroquine Drug for COVID-19 Product Portfolio
- 6.1.5 Zhongsheng Pharma Recent Developments
- 6.2 Sichuan Sunny Hope
- 6.2.1 Sichuan Sunny Hope Company Information
- 6.2.2 Sichuan Sunny Hope Business Overview
- 6.2.3 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sichuan Sunny Hope Chloroquine Drug for COVID-19 Product Portfolio
- 6.2.5 Sichuan Sunny Hope Recent Developments
- 6.3 Shanghai Pharma
- 6.3.1 Shanghai Pharma Company Information
- 6.3.2 Shanghai Pharma Business Overview
- 6.3.3 Shanghai Pharma Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shanghai Pharma Chloroquine Drug for COVID-19 Product Portfolio
- 6.3.5 Shanghai Pharma Recent Developments
- 6.4 Jinghua Pharmaceutical Group
- 6.4.1 Jinghua Pharmaceutical Group Company Information
- 6.4.2 Jinghua Pharmaceutical Group Business Overview
- 6.4.3 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Jinghua Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
- 6.4.5 Jinghua Pharmaceutical Group Recent Developments
- 6.5 North China Pharmaceutical Group
- 6.5.1 North China Pharmaceutical Group Company Information
- 6.5.2 North China Pharmaceutical Group Business Overview
- 6.5.3 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 North China Pharmaceutical Group Chloroquine Drug for COVID-19 Product Portfolio
- 6.5.5 North China Pharmaceutical Group Recent Developments
- 6.6 Guangzhou Baiyunshan Guanghua Pharmaceutical
- 6.6.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Information
- 6.6.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
- 6.6.3 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
- 6.6.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Recent Developments
- 6.7 Bayer
- 6.7.1 Bayer Company Information
- 6.7.2 Bayer Business Overview
- 6.7.3 Bayer Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Bayer Chloroquine Drug for COVID-19 Product Portfolio
- 6.7.5 Bayer Recent Developments
- 6.8 Sun Pharma
- 6.8.1 Sun Pharma Company Information
- 6.8.2 Sun Pharma Business Overview
- 6.8.3 Sun Pharma Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Sun Pharma Chloroquine Drug for COVID-19 Product Portfolio
- 6.8.5 Sun Pharma Recent Developments
- 6.9 Rising Pharmaceutical
- 6.9.1 Rising Pharmaceutical Company Information
- 6.9.2 Rising Pharmaceutical Business Overview
- 6.9.3 Rising Pharmaceutical Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Rising Pharmaceutical Chloroquine Drug for COVID-19 Product Portfolio
- 6.9.5 Rising Pharmaceutical Recent Developments
- 6.10 KPC Group
- 6.10.1 KPC Group Company Information
- 6.10.2 KPC Group Business Overview
- 6.10.3 KPC Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 KPC Group Chloroquine Drug for COVID-19 Product Portfolio
- 6.10.5 KPC Group Recent Developments
- 6.11 CSPC Group
- 6.11.1 CSPC Group Company Information
- 6.11.2 CSPC Group Business Overview
- 6.11.3 CSPC Group Chloroquine Drug for COVID-19 Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 CSPC Group Chloroquine Drug for COVID-19 Product Portfolio
- 6.11.5 CSPC Group Recent Developments
7 North America by Country
- 7.1 North America Chloroquine Drug for COVID-19 Sales by Country
- 7.1.1 North America Chloroquine Drug for COVID-19 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Chloroquine Drug for COVID-19 Sales by Country (2021-2026)
- 7.1.3 North America Chloroquine Drug for COVID-19 Sales Forecast by Country (2027-2032)
- 7.2 North America Chloroquine Drug for COVID-19 Market Size by Country
- 7.2.1 North America Chloroquine Drug for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Chloroquine Drug for COVID-19 Market Size by Country (2021-2026)
- 7.2.3 North America Chloroquine Drug for COVID-19 Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Chloroquine Drug for COVID-19 Sales by Country
- 8.1.1 Europe Chloroquine Drug for COVID-19 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Chloroquine Drug for COVID-19 Sales by Country (2021-2026)
- 8.1.3 Europe Chloroquine Drug for COVID-19 Sales Forecast by Country (2027-2032)
- 8.2 Europe Chloroquine Drug for COVID-19 Market Size by Country
- 8.2.1 Europe Chloroquine Drug for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Chloroquine Drug for COVID-19 Market Size by Country (2021-2026)
- 8.2.3 Europe Chloroquine Drug for COVID-19 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Chloroquine Drug for COVID-19 Sales by Country
- 9.1.1 Asia-Pacific Chloroquine Drug for COVID-19 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Chloroquine Drug for COVID-19 Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Chloroquine Drug for COVID-19 Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Chloroquine Drug for COVID-19 Market Size by Country
- 9.2.1 Asia-Pacific Chloroquine Drug for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Chloroquine Drug for COVID-19 Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Chloroquine Drug for COVID-19 Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Chloroquine Drug for COVID-19 Sales by Country
- 10.1.1 South America Chloroquine Drug for COVID-19 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Chloroquine Drug for COVID-19 Sales by Country (2021-2026)
- 10.1.3 South America Chloroquine Drug for COVID-19 Sales Forecast by Country (2027-2032)
- 10.2 South America Chloroquine Drug for COVID-19 Market Size by Country
- 10.2.1 South America Chloroquine Drug for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Chloroquine Drug for COVID-19 Market Size by Country (2021-2026)
- 10.2.3 South America Chloroquine Drug for COVID-19 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Chloroquine Drug for COVID-19 Sales by Country
- 11.1.1 Middle East and Africa Chloroquine Drug for COVID-19 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Chloroquine Drug for COVID-19 Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Chloroquine Drug for COVID-19 Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Chloroquine Drug for COVID-19 Market Size by Country
- 11.2.1 Middle East and Africa Chloroquine Drug for COVID-19 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Chloroquine Drug for COVID-19 Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Chloroquine Drug for COVID-19 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Chloroquine Drug for COVID-19 Value Chain Analysis
- 12.1.1 Chloroquine Drug for COVID-19 Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Chloroquine Drug for COVID-19 Production Mode & Process
- 12.2 Chloroquine Drug for COVID-19 Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Chloroquine Drug for COVID-19 Distributors
- 12.2.3 Chloroquine Drug for COVID-19 Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst